We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis

By HospiMedica International staff writers
Posted on 16 Apr 2024
Print article
Image: The endoscopic device can 3D image the stiffness of individual biological cells and complex organisms (Photo courtesy of University of Nottingham)
Image: The endoscopic device can 3D image the stiffness of individual biological cells and complex organisms (Photo courtesy of University of Nottingham)

In the early stages of cancer, the cells are significantly softer than normal cells, which facilitates their movement through small spaces and contributes to the rapid spread of the disease, a process known as metastasis. As they spread, these cells alter their surrounding environment to form stiff tumors that offer protection against external threats. Researchers have now developed a groundbreaking endoscopic device capable of 3D imaging the stiffness of individual biological cells and complex organisms, an innovation with the potential to revolutionize early cancer detection and treatment.

The new technology developed by researchers at the University of Nottingham (Nottingham, UK) allows for stiffness measurement of these individual cells using a hair-thin endoscopic probe. This advancement enables, for the first time, the performance of histology (or investigating microscopic cellular tissue) based on abnormal stiffness at the single cell level inside the body. The device achieves exceptionally high imaging resolution by utilizing a phenomenon known as Brillouin scattering, where a laser beam interacts with the natural stiffness of the material being examined, allowing it to detect the stiffness of objects down to billionths of a meter (nanometers).

The application of this technology aided biologists in visualizing the 3D stiffness of a microscopic organism, Caenorhabditis elegans, a nematode commonly used in scientific research. This tool provided detailed visual and material information about a previously difficult-to-image part of the organism’s anatomy, the cuticle, which had only been imaged under non-living conditions using electron microscopes until now.

“We aim to develop new endoscopic technologies that make diagnostics faster, safer, and clearer for both patients and clinicians. Typically, histopathology requires destructive, invasive biopsies that are not only uncomfortable and potentially damaging for the patient, but require significant logistics such as chemical processing, transportation, and analysis,” said Dr. Salvatore La Cavera III from the University of Nottingham. “Our device makes it possible to ‘feel for a stiff lump,’ but on a single cellular scale, meaning we could catch cancer early at microscopic cell scales rather than large malignant tumor scale. It is non-invasive, non-toxic, and very promisingly, is related to technology that can quantitatively determine the presence of cancer cells using artificial intelligence – providing a chronically understaffed area with a much-needed solution to a real-world problem that the industry has faced for decades.”

Related Links:
University of Nottingham

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
Compact C-Arm
Arcovis DRF-C S21

Print article


Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.